| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.034 | 0.2 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.2 |